0.1721
Precedente Chiudi:
$0.159
Aprire:
$0.1526
Volume 24 ore:
114.39K
Relative Volume:
0.39
Capitalizzazione di mercato:
$4.47M
Reddito:
-
Utile/perdita netta:
$-4.23M
Rapporto P/E:
-0.8164
EPS:
-0.2108
Flusso di cassa netto:
-
1 W Prestazione:
+1.24%
1M Prestazione:
-33.83%
6M Prestazione:
-64.15%
1 anno Prestazione:
+0.00%
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Nome
Klotho Neurosciences Inc
Settore
Industria
Telefono
646-916-5315
Indirizzo
1115 BROADWAY, NEW YORK
Confronta KLTO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
KLTO
Klotho Neurosciences Inc
|
0.1721 | 4.47M | 0 | -4.23M | 0 | -0.2108 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Klotho Neurosciences Inc Borsa (KLTO) Ultime notizie
Form PRE 14AOther preliminary proxy statements - ADVFN
Klotho Neurosciences faces Nasdaq delisting risk By Investing.com - Investing.com South Africa
Klotho Neurosciences faces Nasdaq delisting risk - Investing.com
Klotho Neurosciences receives Nasdaq compliance extension - Investing.com Australia
Klotho Neurosciences receives Nasdaq compliance extension By Investing.com - Investing.com Canada
KLTO stock touches 52-week low at $0.19 amid sharp annual decline - Investing.com India
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Klotho Neurosciences to Acquire SkyBell Tech Subsidiary By Investing.com - Investing.com South Africa
Klotho Neurosciences to Acquire SkyBell Tech Subsidiary - Investing.com
Klotho Neurosciences, Inc. SEC 10-K Report - TradingView
Klotho Neurosciences Inc. (KLTO) reports earnings - qz.com
KLTO stock touches 52-week low at $0.25 amid sharp annual decline - Investing.com Canada
Exelixis (NASDAQ:EXEL) & Klotho Neurosciences (NASDAQ:KLTO) Financial Analysis - Defense World
Pre-market Movers: BTAI, VRPX, DCGO, NBY... - RTTNews
Klotho Neurosciences faces Nasdaq delisting By Investing.com - Investing.com Australia
Klotho Neurosciences faces Nasdaq delisting - Investing.com India
Citigroup Begins Coverage on Candel Therapeutics (NASDAQ:CADL) - Defense World
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Critical Comparison: Klotho Neurosciences (NASDAQ:KLTO) versus IN8bio (NASDAQ:INAB) - Defense World
Klotho Neurosciences, Inc. announced that it expects to receive $2 million in funding -January 22, 2025 - Marketscreener.com
Klotho Neurosciences secures $2M in convertible notes and warrants By Investing.com - Investing.com Canada
Klotho Neurosciences secures $2M in convertible notes and warrants - Investing.com India
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco - The Manila Times
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Head to Head Contrast: Klotho Neurosciences (NASDAQ:KLTO) & ImmunityBio (NASDAQ:IBRX) - Defense World
Klotho Neurosciences, Inc. announced that it has received $1 million in funding from ACM Projektentwicklung GmbH - Marketscreener.com
Klotho Neurosciences secures $1.2 million convertible note By Investing.com - Investing.com Canada
Klotho Neurosciences secures $1.2 million convertible note - Investing.com India
Klotho Neurosciences, Inc. Appoints Dr. Merit Cudkowicz to Scientific Advisory Board - Marketscreener.com
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board - The Manila Times
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts - GlobeNewswire
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board - Yahoo Finance
Former Merck USA President Joins Klotho Neurosciences' Board of Directors - The Manila Times
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors - GlobeNewswire
Klotho Neurosciences Taps Former Merck US President Who Led $12B Portfolio to Board of Directors - StockTitan
Riad El-Dada Joins Klotho Neurosciences’ Board of Directors - citybiz
Klotho Neurosciences expands Board with seasoned healthcare executive By Investing.com - Investing.com Canada
Klotho Neurosciences expands Board with seasoned healthcare executive - Investing.com
Klotho Neurosciences, Inc. and Teleost Biopharmaceuticals, LLC Terminate Licensing Agreement - Marketscreener.com
EDIT Stock Drops Amid Market Volatility in Biotech Sector - GuruFocus
Klotho Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Klotho Neurosciences Inc Azioni (KLTO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):